InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,870.62
(
-1.32%
)
US TECH 100
19,880.00
(
-2.30%
)
Dow Jones
43,444.99
(
-0.70%
)
Brent Oil
71.15
(
0.62%
)
Bitcoin
91,659.71
(
2.00%
)
Post# of 253651
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

JJM760

Send PM Follow Ignore
Followers 5
Posts 993
Boards Moderated 0
Alias Born 06/15/2010

JJM760

Re: jq1234 post# 167915

Thursday, 10/10/2013 3:50:17 PM

Thursday, October 10, 2013 3:50:17 PM

Post# of 253651
Correct me if I am wrong, Aria and its shareholders lost approx 2.5 bil in MC due mainly to the fact that approx an additional 17-18 pts (who were very sick and pretreated with Gleevec/Tasigna/Sprycel) developed AT.

And there no way to qualify G/T/S contribution to the events, correct?

If I were a BP I would make a 2 bil hostile offer (if necessary) and run all Ponatinib trials at 30/15 mg (45 where necessary) and you would have a very nice ROI in a reasonable time.


Disclosure: I am out of Ariad
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up